DK1383897T3 - Selv-containing Lactococcus-stamme - Google Patents

Selv-containing Lactococcus-stamme

Info

Publication number
DK1383897T3
DK1383897T3 DK02740565T DK02740565T DK1383897T3 DK 1383897 T3 DK1383897 T3 DK 1383897T3 DK 02740565 T DK02740565 T DK 02740565T DK 02740565 T DK02740565 T DK 02740565T DK 1383897 T3 DK1383897 T3 DK 1383897T3
Authority
DK
Denmark
Prior art keywords
self
survive
lactococcus strain
medium
containing lactococcus
Prior art date
Application number
DK02740565T
Other languages
Danish (da)
English (en)
Inventor
Lothar Steidler
Original Assignee
Vlaams Interuniv Inst Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vlaams Interuniv Inst Biotech filed Critical Vlaams Interuniv Inst Biotech
Application granted granted Critical
Publication of DK1383897T3 publication Critical patent/DK1383897T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y201/00—Transferases transferring one-carbon groups (2.1)
    • C12Y201/01—Methyltransferases (2.1.1)
    • C12Y201/01045—Thymidylate synthase (2.1.1.45)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
DK02740565T 2001-05-03 2002-05-03 Selv-containing Lactococcus-stamme DK1383897T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01201631 2001-05-03
EP01204785 2001-12-07

Publications (1)

Publication Number Publication Date
DK1383897T3 true DK1383897T3 (da) 2006-10-30

Family

ID=26076897

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02740565T DK1383897T3 (da) 2001-05-03 2002-05-03 Selv-containing Lactococcus-stamme

Country Status (9)

Country Link
EP (1) EP1383897B1 (enExample)
JP (2) JP4347575B2 (enExample)
AT (1) ATE331789T1 (enExample)
AU (1) AU2002314040B2 (enExample)
CA (1) CA2446776C (enExample)
DE (1) DE60212825T2 (enExample)
DK (1) DK1383897T3 (enExample)
ES (1) ES2266515T3 (enExample)
WO (1) WO2002090551A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7780961B2 (en) 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
DE60319822T2 (de) 2002-06-19 2009-06-04 Actogenix Nv Verfahren und mittel zur erhöhung der darmabsorption
WO2004056850A2 (en) * 2002-12-19 2004-07-08 Vib Vzw Mutant proteins showing increased secretion
JP4589618B2 (ja) * 2003-11-28 2010-12-01 独立行政法人農業生物資源研究所 免疫調節性機能を誘導する乳酸菌類とその成分
WO2006018446A2 (en) * 2004-08-20 2006-02-23 Actogenix Nv Method to improve lactococcus preservation
DK2119450T3 (da) * 2005-11-29 2013-05-06 Actogenix Nv Induktion af mucosal tolerance over for pankreatisk ø-beta-celle-autoantigener
CA2672229A1 (en) * 2006-12-14 2008-06-19 Actogenix N.V. Delivery of binding molecules to induce immunomodulation
CN101605900B (zh) * 2007-01-12 2014-04-23 阿克图杰尼斯公司 乳球菌启动子和其用途
BRPI0807857A2 (pt) 2007-01-25 2014-05-27 Actogenix Nv Tratamento de doença imune por meio de distribuição através da mucosa de antígenos.
JP2012504116A (ja) * 2008-09-29 2012-02-16 アクトジェニックス・エヌブイ 粘膜での微生物のコロニー形成の低減
EP2714912B1 (en) 2011-06-01 2018-05-02 Intrexon Actobiotics NV Polycistronic expression system for bacteria
HUE038830T2 (hu) 2011-09-23 2018-11-28 Intrexon Actobiotics Nv Módosított gram-pozitív baktériumok és alkalmazásaik
CN103917639B (zh) 2011-09-23 2017-09-26 英特瑞克斯顿阿克图比奥帝克斯有限公司 经修饰的革兰氏阳性细菌及其用途
US9688967B2 (en) 2014-12-05 2017-06-27 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
US20160206666A1 (en) 2014-12-22 2016-07-21 Synlogic, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
KR20170121291A (ko) * 2015-03-02 2017-11-01 신로직 인코포레이티드 감소된 창자 염증 및/또는 강화된 창자 점막 장벽으로부터 이익을 얻는 질병을 치료하기 위해 공학처리된 박테리아
CN106148254B (zh) * 2015-03-26 2019-11-12 南京华贞生物医药科技有限公司 一种用于减肥降脂的转化体及其构建方法与应用
EP3882259B1 (en) 2015-05-13 2026-01-28 Synlogic Operating Company, Inc. Bacteria engineered to reduce hyperphenylalaninemia
US11685925B2 (en) 2015-10-30 2023-06-27 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
JP6993970B2 (ja) 2015-11-16 2022-02-15 シンロジック オペレーティング カンパニー インコーポレイテッド 高フェニルアラニン血症を低減させるように操作された細菌
JP7292877B2 (ja) 2016-01-14 2023-06-19 イントレクソン・アクトバイオテイクス・エヌブイ １型糖尿病を処置するための組成物および方法
US10858663B2 (en) 2016-09-02 2020-12-08 Intrexon Actobiotics N.V. Genetically modified bacteria stably expressing IL-10 and insulin
KR102469701B1 (ko) 2016-09-13 2022-11-22 인트랙슨 액토바이오틱스 엔.브이. 점막부착성 미생물
EP3642221A1 (en) 2017-06-21 2020-04-29 Synlogic Operating Company, Inc. Bacteria for the treatment of disorders
EP3864048A1 (en) 2018-10-11 2021-08-18 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Bacteria expressing single chain antibodies against toll-like receptors
CA3156035A1 (en) 2019-09-27 2021-04-01 Intrexon Actobiotics Nv D/B/A Precigen Actobio Treatment of celiac disease
WO2021188819A1 (en) 2020-03-20 2021-09-23 Synlogic Operating Company, Inc. Microorganisms engineered to reduce hyperphenylalaninemia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4231764A1 (de) * 1992-09-23 1994-03-24 Inst Pflanzengenetik & Kultur Verfahren zur chromosomalen Integration eines Produkt-Gens

Also Published As

Publication number Publication date
JP2004533246A (ja) 2004-11-04
ATE331789T1 (de) 2006-07-15
JP4347575B2 (ja) 2009-10-21
CA2446776A1 (en) 2002-11-14
DE60212825T2 (de) 2007-01-11
ES2266515T3 (es) 2007-03-01
DE60212825D1 (de) 2006-08-10
EP1383897A2 (en) 2004-01-28
CA2446776C (en) 2011-07-12
JP2009060913A (ja) 2009-03-26
WO2002090551A2 (en) 2002-11-14
EP1383897B1 (en) 2006-06-28
WO2002090551A3 (en) 2003-03-27
AU2002314040B2 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
ATE331789T1 (de) Selbsterhaltender lactococcus stamm
WO2004046346A3 (en) Self-containing lactobacillus strain
DE60111570D1 (de) Isoindolin-1-on als glukokinaseaktivatoren
NO20091976L (no) Nye forbindelser
ATE476439T1 (de) Amplifikationsblocker umfassend interkalierende nukleinsäuren (ina) enthaltend interkalierende pseudonukleotide (ipn)
USD527040S1 (en) Type font
DK1391502T3 (da) Værtsmikroorganismer
DK1668001T3 (da) Substituerede heteroarylbenzofuransyrer
EP1678315A4 (en) ZINC FINGER PROTEINS FROM GENETIC GENE FOR REGULATING GENE EXPRESSION
GB2403358B (en) Digital pre-distortion for the linearizazion of power amplifiers with asymetrical characteristics
AU2003296668A1 (en) Sodium percarbonate particles with improved storage stability
ATE468627T1 (de) Disc-monopol-antennenstruktur
ITVA20020050A1 (it) Metodo e circuito di amplificazione con pre-enfasi.
AU2003218099A1 (en) Modulation of the immune response through the manipulation of arginine levels
SG149058A1 (en) Live genetically attenuated malaria vaccine
AU2003214098A1 (en) Ceramic colorants in the form of nanometric suspensions
TW200708929A (en) Opposite-phase scheme for peak current reduction
PL377176A1 (pl) N-Sulfonylo-4-metylenoamino-3-hydroksy-2-pirydony
AU2003227457A1 (en) Comparison of source files
AU2003245134A1 (en) Oxytocin as cardiomyogenesis inducer and uses thereof
AU2002302624A1 (en) Process for the preparation of d-pantothenic acid and/or salts thereof
ATE298471T1 (de) Zweidimensionale pyramidenfilterarchitektur
MXPA05005574A (es) Compuestos calciliticos.
DE60224026D1 (de) Rechen
ATE402998T1 (de) D-hydantoinase aus ochrobactrum anthropi